Posted by Michael Wonder on 28 Apr 2021
EYEMATE system for remote glaucoma management obtains FDA breakthrough device designation
28 April 2021 - - Implandata Ophthalmic Products has announced today that its game-changing EYEMATE system for digitally enabled remote patient monitoring and management of glaucoma has obtained breakthrough device designation from the U.S. FDA.
The patented EYEMATE system is the world’s only clinically-validated product used for comprehensive remote glaucoma monitoring.
